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A B S T R A C T
Pentacyclic triterpenes are a large family of plant metabolites that exhibit a wide array 
of biological activities. The genus Cecropia, which encompasses many plant species, has 
been used as traditional medicine for the treatment of inflammatory diseases and is 
known to produce many active pentacyclic triterpenes. In this study we investigated 
the chemical composition of a pentacyclic triterpene fraction from the roots of Cecropia 
telenitida Cuatrec., Urticaceae. A novel compound, which we termed yarumic acid, 
and four known molecules (serjanic acid, spergulagenic acid A, 20-hydroxy-ursolic 
acid and goreishic acid I) were isolated and characterised. In a dendritic cell (DC)-
based assay, we demonstrated that non-toxic doses of these pentacyclic triterpenes 
inhibited the secretion of at least one of the proinflammatory cytokines tested (IL-1E, 
IL-12p40, IL-12p70, TNF-D). Spergulagenic acid A also inhibited nitric oxide production 
in lipopolysaccharide-stimulated dendritic cell. Serjanic acid and spergulagenic acid 
A, which were the most potent abundant compounds in the pentacyclic triterpene 
fraction, showed the most activity in the dendritic cell-based assay. These results show 
that all pentacyclic triterpenes might contribute to the anti-inflammatory activities of 
C. telenitida. Moreover, yarumic acid as well as the four known pentacyclic triterpenes, 
can be exploited as potential immunomodulatory/anti-inflammatory agents.
© 2013 Elsevier Editora Ltda. 
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Introduction 
Pentacyclic triterpenes (PT) are secondary plant metabolites 
that are widely distributed in many species within the 
plant kingdom and therefore throughout the world. These 
metabolites are found in varying amounts in edible vegetables 
and fruits, making them important constituents of the human 
diet (Jäger et al., 2009; Laszczyk, 2009; Saleem, 2009; Siddique 
and Saleem, 2011). Consumption of this class of naturally 
occurring substances appears to be associated with the 
prevention of a variety of human diseases (Laszczyk, 2009; 
Siddique and Saleem, 2011). Phytochemical investigations of 
medicinal plants used in folk medicine have also consistently 
implicated PT as one of the most prominent chemical groups 
responsible for the pharmacological activity of the derived 
natural products (Poeckel and Werz, 2006; Ríos, 2010; Saleem, 
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2009). In vitro and in vivo animal studies have demonstrated the 
potential of prototypical PT, such as lupeol and betulinic acid, 
as well as ursolic, boswellic and oleanolic acid derivatives, 
to prevent and/or treat a spectrum of diseases that range 
from cancer and infection to diabetes and rheumatic and 
cardiovascular diseases (Laszczyk, 2009; Sheng and Sun, 
2011; Siddique and Saleem, 2011). Interestingly, most of PT 
studied thus far exhibit immunomodulatory activity, as they 
inhibit one or several pathways involved in the inflammatory/
immune response (Ríos, 2010; Saleem, 2009). Therefore, 
modulation of the immune system is emerging as a central 
mechanism that explains, at least in part, the multi-targeting 
properties of PT.
Dendritic cells (DC) are a class of leucocytes that play an 
essential role in the initiation and regulation of the immune 
response. As the strongest antigen-presenting cell (APC), DC 
have a unique ability to activate naïve T cells and coordinate 
the subsequent adaptive response towards different pathways, 
including inflammatory responses (such as Th1, Th2, Th17 
etc.) and regulatory responses (such as Tr1, Th3 and other 
regulatory T cells). Typically, tissue-resident DC are activated 
by mediators either produced by microbial pathogens (also 
known as pathogen-associated molecular patterns, PAMP) 
or delivered by dying/stressed cells (also known as danger-
associated molecular patterns, DAMP) and respond by 
undergoing a differentiation process called maturation. 
Maturation allows DC to coordinate the upregulation of surface 
molecules associated with antigen presentation (such as MHC 
class II and costimulatory molecules) and cytokine/chemokine 
secretion with migration to lymphoid organs. In the lymphoid 
organs, maturing DC stimulate lymphocyte proliferation and 
differentiation (Steinman and Hemmi, 2006). Secretion of pro-
inflammatory cytokines by DC appears to be a prominent event 
that initiates and sustains chronic inflammatory responses, 
making this cell type a potential target to develop strategies 
against chronic inflammatory diseases (Chan et al., 2012; 
Farkas and Kemény, 2012). Because the majority of clinically 
available anti-inflammatory/immunosuppressive drugs are 
potent inhibitors of cytokine production by DC (Hackstein and 
Thomson, 2004), natural and synthetic compounds that exhibit 
this inhibitory effect on DC are considered to be promising 
anti-inflammatory/immunosuppressive leads.
Cecropia ,  Urticaceae, is a neotropical genus fre-
quently found in humid areas up to 2600 m above 
sea level. Species of Cecropia  occur from Mexico to 
northern Argentina. In contrast, the distribution of 
C. telenitida (Franco-Roselli and Berg, 1997), retrieved from the 
Tropicos database (Missouri Botanical Garden), shows that 
this species is restricted to the central and northern sections 
of the Andes Mountains (Venezuela, Colombia, Ecuador and 
Peru). Despite the fact that C. telenitida has not been well stud-
ied with regards to its chemistry and bioactivity, the genus 
has a large record of phytochemical descriptions (Costa et al., 
2011; Rocha et al., 2007; Schinella et al., 2008). Chlorogenic 
acid and isoorientin are two recognised secondary metabo-
lites identified in the leaves of C. obstusifolia and C. pachys-
tachya, whereas PT are broader chemotaxonomic markers in 
roots of the plants belonging to this genus (Andrade-Cetto and 
Vázquez, 2010). The principal ethnopharmacological appli-
cations of Cecropia are for inflammation and the treatment 
of type 2 diabetes (Alonso-Castro et al., 2008; Andrade-Cetto 
and Vázquez, 2010; Aragão et al., 2010; Revilla-Monsalve et 
al., 2007; Schinella et al., 2008). In our search for naturally 
occurring bioactive compounds from the Colombian flora, we 
initiated a phytochemical investigation of Cecropia telenitida 
(vernacular names Guarumo, Guarumbo or Yarumo Plateado). 
Our preliminary studies indicated the presence of abundant 
PT in the roots. We also examined the composition of a PT 
fraction from the roots of Cecropia telenitida and evaluated its 
immunomodulatory potential in vitro by using DC as a read 
out system. Our results showed the presence of a novel com-
pound that we have termed yarumic acid (1), along with other 
four known PT. The immunomodulatory activity of all of the 
isolated PT as well as the total PT fraction is also reported.
Materials and methods
General experimental procedures
Methanol, ethyl acetate and n-hexane were purchased 
from Merck (Darmstadt, Germany). Deionised water was 
obtained from a Milli-Q water purification system (Millipore, 
Bedford, MA, USA). Ammonium acetate and formic acid 
were purchased from Sigma-Aldrich Chemie (Deisenhofen, 
Germany). NMR experiments were performed on Bruker DRX-
400 and 600 spectrometers (Bruker, Rheinstetten, Germany) 
equipped with an HX inverse probe (1H NMR: 400 MHz; 13C: 
100 MHz; 1H: 600 MHz; 13C: 150 MHz). 1H NMR, 13C NMR, H-H 
correlation (COSY), 1D and 2D distortionless enhancement 
by polarisation transfer (DEPT), and heteronuclear multiple 
quantum/bond coherence/correlation (HMQC/HMBC) 
were recorded using standard Bruker pulse sequences. 
System control and data evaluation was performed with 
the XWINNMR software package, version 2.6 (Bruker, 
Rheinstetten, Germany). Chemical shifts (G) are expressed 
in ppm. The centre of the peak for each deuterated solvent 
was used as an internal reference (CD3OD G 4.78 and 3.31, 
CDCl3 G 7.24, and DMSO-d6 G 2.5 ppm).
HPLC separations were performed on an Agilent 1200 
Series HPLC system (Agilent, Waldbronn, Germany). The 
separations were carried out on a C18 analytical column 
(250 mm × 4.6 mm, 5 μm; Agilent Zorbax Bonus RP) at 35°C 
and a C18 preparative Supelcocolumn (250 mm × 21.2 mm, 
5 μm). The mobile phase (water: methanol) was comprised 
of 70 to 100% of methanol from 0 to 10 min and isocratic 
100% methanol from 10 to 15 min. Ammonium acetate 
(5 mM) was added to the mobile phase to promote the 
negative ionisation mode. The flow rate was set at 
0.8 ml/min. System control and data evaluation was 
performed using the Agilent LC/MSD Chemstation software 
package. APCI/MS was performed by means of the LC/MSD 
ion trap (Agilent, Waldbronn, Germany). The instrumental 
parameters of APCI were as follows: capillary voltage +2000; 
corona, 10000 nA; nebuliser pressure, 60 psi; dry gas flow, 
5 l/min; dry gas temperature, 350°C; vaporiser temp, 400°C 
and skimmer voltage, -40V. The instrument was operated 
in negative mode. The full mass scanning range was m/z 
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400 to 600. To avoid the interference from background, the 
selected ion monitoring (SIM) mode was also used for some 
of the samples.
Plant material, extraction of triterpene fractions and 
isolation of compounds
The roots of Cecropia telenitida Cuatrec., Urticaceae, were 
obtained in La Ceja, Antioquia (parcel “el Yarumo”); the 
specimens were deposited in the Universidad de Antioquia 
herbarium (voucher: Alzate 2870, HUA). Air-dried roots of 
C. telenitida (2 kg) were cleaned with n-hexane and ethanol 
and then extracted with ethyl acetate. The ethyl acetate 
extract was concentrated (112 g), diluted in methanol 
and purified by Sephadex LH-20 using medium pressure 
liquid chromatography to eliminate molecules with a 
high molecular weight, such as polymers. The fractions 
containing triterpenes (1% yield; detection sulphuric acid/
anisaldehyde reagent) were pooled and used for analytical 
and biological assays (20 g). Conventional isolations from 
preparative HPLC were used to purify the molecules. 
Serjanic (2) (1,450 g, 0.07% yield) and spergulagenic A 
(3) acids (0,700 g, 0.03% yield) were the most abundant 
triterpenes from C. telenitida roots, followed by yarumic acid 
(1) (200 mg, 0.01% yield). Other triterpenes were present at 
less than 5 mg (20-hydroxy-ursolic acid (4) and goreishic 
acid I (5)). Stock solutions of purified triterpenes and total 
triterpenefraction were prepared in DMSO (2 mg/ml).
Mice and bone marrow cell preparation
C57BL/6 mice obtained from Charles River Laboratories 
(Wilmington, MA) and were bred and housed under 
barrier conditions at the SPF animal facility of the Sede 
de Investigacion Universitaria (SIU) at Universidad 
de Antioquia. All procedures involving animals were 
approved by the inst i tut ional  ethical  committee. 
Serological and microbiological tests were periodically 
performed on the mice colony, and results showed 
that the mice were pathogen-free. To obtain total bone 
marrow cells, female C57BL/6 mice (8-12 weeks old) were 
sacrificed, and the femurs and tibiae were aseptically 
removed. A tuberculin syringe was then used to flush the 
bone marrow cell content and to obtain a homogeneous 
cell suspension. 
Dendritic cells (DC) generation and treatments
DC were generated from bone marrow precursors according 
to the method reported by Lutz et al. (Lutz et al., 1999), with 
minor modifications. Briefly, 2 × 105 cells/ml bone marrow 
cells were washed and cultured in RPMI 1640 (Glutamax, GIBCO, 
USA) supplemented with 10 mM HEPES, 2 mM L-glutamine, 
10% FBS, 50 μM E-mercaptoethanol and recombinant 
murine granulocyte/macrophage colony-stimulating factor 
(mGM-CSF, 200 U/ml). Cultures were incubated in 5% CO2 
atmosphere at 37 °C. On days 3 and 6 of culturing, fresh medium 
containing mGM-CSF (200 U/ml) was added. Non-adherent 
cells were collected on day 9, washed and resuspended at 
1 × 106 cells/ml in fully supplemented culture medium for 
further use. These cells were morphologically, phenotypically 
(CD11c+ CD11b+ MHC class II+ Gr1- CD4- CD8- CD19-) and 
functionally (potent APC in allogeneic mixed leucocyte 
reactions) consistent with DC (data not shown). 
A 1 ml cell suspension containing 1 × 106 cells was 
seeded in 24-well plates and cultured in the presence of 
10 μg/ml of either purified triterpenes or the total triterpene 
fraction. Vehicle (0.5% DMSO) and dexamethasone (3.16 μg/ml, 
Alexis Biochemicals; also prepared in 0.2% v/v DMSO as vehicle) 
treatments were used as negative and positive controls, 
respectively. After a 6 h incubation, cells were stimulated 
with LPS (0.1 μg/ml, Sigma) for additional 18 h. DC cultures 
incubated in the absence of LPS were set as the non-stimulated 
controls. Cell-free supernatants were collected for further 
assessment of cell viability, cytokine secretion and nitric oxide 
(NO) production.
Cell viability, cytokine and nitric oxide measurements
DC viability was determined by quantifying the activity 
of the enzyme lactate dehydrogenase released from the 
cytosol of DC into the supernatant. For this purpose, 
a Cytotox 96® Non-radioactive cytotoxicity assay kit 
(Promega, USA) was used following the manufacturer’s 
protocol. The percentage of viable cells was calculated with 
the following formula: % viability = 100 – [Experimental 
LDH release (OD490)/Maximum LDH release (OD490)]. The 
concentrations of the cytokines IL-1E, IL-6, IL-12p40, 
IL-12p70, and TNF-D were determined using Luminex 
technology and a customised multiplexed kit (Bioplex 
multiplex mouse cytokine assay kit, Bio-Rad, Hercules, 
CA), according to the manufacturer’s protocol. Data were 
collected by using the Bio-Plex suspension array system 
and analysed with the Bio-Plex Manager™ (Bio-Rad, USA) 
(Lash et al., 2006). The limits of detection of this method 
for IL-1E, IL-6, IL-12p70, TNF-D, and IL-12p40 were 9.4, 
0.2, 2.3, 1.4, and 0.4 pg/ml, respectively. Nitric oxide (NO) 
production was measured as nitrite equivalents with the 
Griess reaction in cell-free supernatants as previously 
reported (Sun J et al., 2003).
Results and discussion
Structural elucidation of yarumic acid (1)
From an extract derived from the roots dissolved in ethyl 
acetate, an unknown pentacyclic triterpene, which we have 
defined as yarumic acid (1), was isolated and characterised. 
The exact and unambiguous properties of this compound 
were made by interpreting the 1H, 13C, DEPT, COSY, HMQC 
and HMBC spectra. The stereochemistry of the five ring 
systems was established by their NOESY and COSY spectra. 
The elemental composition of C30H48O5 (487.3429) was 
determined by means of APCI-TOF-MS m/z 487.3456 (5.54 ppm 
error). The 13C-NMR spectra displayed thirty carbon atoms, 
with one carbonyl at G 177.46 (qC) and two olefin carbons at 
G 139.93 (qC) and 131.34 (qC). By dissimilarity with the DEPT135 
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experiment, six quaternary carbons were identified in addition 
to seven methyl, nine methylene and five methine groups. 
Three resonances for carbons bearing oxygen were observed 
at G 83.54 (qC), 82.99 (CH) and 68.28 (CH). From the HMBC 
experiment, the double bond was located by CH3-27 to C-13 and 
CH3-29 to C-18 correlations. The relative configuration of the 
hydroxyl at C-2 was deduced to be D (axial) by strong NOESY 
correlations at the 2-E-H position with 23-Hs, 23-Hs with 25-Hs 
and 25-Hs with 26-Hs. Moreover, 3-D-H (doublet) had a coupling 
constant of G 9.6, which is suggests to be anti-periplanar to 
2-E-H. The 3-D-H position was confirmed by NOESY from 5-D-
H, 5-D-H with 9-D-H and 9-D-H with 27-Hs. The 30-E-methyl 
position was indicated by NOESY from the 19-E-H. Some of the 
correlations mentioned above are shown in Fig. 1.
Compound 1: pale yellow amorphous powder; 13C-NMR 
(100 MHz, CD3OD G ppm) see table 1. 1H-NMR (400 MHz, CD3OD 
G ppm) 2.10 (1H, m, H-1b), 0.95 (1H, m, H-1a), 3.65 (1H, m, H-2), 
2.94 (1H, d, H-3), 0.88 (1H, m, H-5), 1.60 (2H, m, H-6), 1.51 (2H, m, 
H-7), 1.62 (1H, m, H-9), 2.05 (1H, m, H-11a), 2.51 (1H, d, H-11b), 
1.67 (2H, m, H-12), 1.64 (2H, m, H-15), 2.23 (2H, m, H-16), 2.70 
(1H, d, H-19), 1.57 (2H, m, H-21), 1.83 (2H, m, H-22), 1.02 (3H, s, 
H-23), 0.80 (3H, s, H-24), 0.97 (3H, s, H-25), 0.86 (3H, s, H-26), 1.19 
(3H, s, H-27), 1.09 (3H, d, H-29), 1.39 (3H, s, H-30). HRESIMS m/z 
487.3456 (calcd. for C30H48O5 487.3429). ESI-IT-MS
2 [M]-m/z 487, 
MS2: m/z 469.2 (100), 453.2 (15), 441.2 (19), 425.2 (12). 
 
Compunds
Position
1 2 3 4 5
1 47.0 38.0 38.0 38.7 48.0
2 68.1 26.9 23.3 27.4 67.7
3 82.8 76.8 80.9 77.3 82.7
4 38.9 38.3 45.8 38.8 39.4
5 55.2 54.8 55.3 55.2 55.3
6 18.1 18.0 18.1 18.5 18.5
7 34.6 32.4 32.5 33.2 34.6
8 42.9 38.8 39.2 37.0 39.0
9 50.6 47.1 47.5 47.5 47.7
10 38.1 36.6 23.5 37.0 38.0
11 27.3 22.8 27.6 23.3 28.4
12 21.2 121.9 123.2 125.0 125.3
13 139.9 143.5 142.9 138.7 138.9
14 42.3 41.2 41.3 42.1 44.6
15 26.9 27.2 27.6 28.0 23.2
16 24.9 22.7 23.0 24.3 31.2
17 41.2 44.9 37.6 39.8 48.9
18 131.3 42.0 42.2 52.8 133.6
19 39.8 41.6 41.9 38.9 135.0
20 83.5 43.2 43.7 74.3 34.2
21 32.8 29.7 30.3 29.5 26.5
22 32.0 33.2 33.5 36.8 34.9
23 27.7 28.2 28.0 28.7 29.3
24 15.8 16.0 15.3 16.5 17.7
25 16.7 15.1 14.1 15.7 17.5
26 16.8 16.7 16.6 17.4 18.2
27 19.3 25.5 25.8 23.7 22.0
28 177.5 178.1 183.5 178.8 177.4
29 15.5 27.8 28.3 17.5 19.5
30 21.5 176.2 176.9 21.5 19.0
31  51.5 3.6   
32   171.0   
33   21.2   
Table 1 
13C NMR Data of Compounds 1-5.
Fig. 1 - Experimental correlations in NOESY and HMBC 
observed in compound 1.
The structures of four additional oleanane-type triterpenes 
isolated from C. telenitida were established on the basis of 
spectral analyses and compared to data previously reported 
(Begum et al., 2002a; Numata A et al., 1990; Razdan et al., 1983). 
The 13C-NMR data of the isolated pentacyclic triterpenes are 
shown in Table 1. The molecules were characterised and also 
traced in the total PT fraction by tandem mass spectrometry. 
The negative MS spectrum in SIM mode of all of the pentacyclic 
triterpenes was used to control for the different batches of PT 
fractions and therefore confirm the presence of more abundant 
triterpenes (Fig. 2). Following isolation, compounds 1, 2, 3, 4, 
and 5, as well as the total PT fraction, were further evaluated 
in LPS-stimulated DC.
Immunomodulatory activity of compounds on dendritic cells
DC have been recognised as crucial players during the 
initiation and maintenance of pathological inflammation 
largely through their ability to secrete proinflammatory 
cytokines and trigger a subsequent inflammatory adaptive 
immune response (Chan et al., 2012; Farkas and Kemény, 
2012; Steinman and Hemmi, 2006). Thus, natural products 
that interfere with proinflammatory pathways in DC are by 
definition potential promoters of immune regulation and thus 
possible anti-inflammatory agents (Hackstein and Thomson, 
2004; Svajger et al., 2010). An increasing number of reports that 
assessed the effect of natural products in the form of crude 
NOESY
HMBC
Structural information of known pentacyclic triterpenes
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extracts, fractions or isolated compounds in DC has been 
reported in recent years (Figueirinha et al., 2010; Freysdottir 
et al., 2011; Kwon et al., 2011; Liu et al., 2008; Mitsui et al., 
2010; Wismar et al., 2011). However, to our knowledge, little 
information is available on the immunomodulatory capacity 
of Cecropia ssp., and no information regarding either cytokine 
production or DC modulation by C. telenitida metabolites 
has been reported. Although four of the PT identified in this 
study have been isolated from other natural sources (Begum 
et al., 2002b; Dini et al., 2002; Dini et al., 2001; Galarraga et 
al., 2010; Hänsel and Kußmaul, 1975; Montoya et al., 2009), 
no effects on proinflammatory cytokine production and DC 
functions have been assessed. We prepared DC from C57BL/6 
mice and determined the ability of PT from C. telenitida to 
modulate cytokine secretion using a multi-analyte luminex 
assay. Previous experiments demonstrated that none of 
the isolated compounds or the total PT fraction exerted either 
a cytotoxic effect or cytokine-inducing activity in resting 
DC (data not shown). LPS treatment induced prominent 
increases of  IL-1E  (2596 +/-  404 pg/ml) ,  IL-12p40 
(21013 +/- 4955 pg/ml), IL-12p70 (732 +/- 109 pg/ml), 
TNF-D (12338 +/- 3108 pg/ml) and IL-6 (7652 +/- 1609 pg/ml) 
levels. The effect of pre-treatment with either the PT fraction 
or isolated compounds was determined in LPS-stimulated 
DC. Cells treated with dexamethasone and vehicle were 
used as positive and negative control cultures, respectively. 
At the concentration tested, none of the treatments affected 
cell viability in LPS-activated DC (Fig. 3). As expected, 
dexamethasone exhibited a profound anti-inflammatory 
effect in DC, as evidenced by the almost complete abrogation 
of LPS-induced IL-1E, IL-12p40, IL12p70 and TNF-D secretion 
(70-90% inhibition, Fig. 3) and the pronounced inhibition of 
IL-6 secretion (47%, data not shown). Nitric oxide production 
was also inhibited by dexamethasone (Fig. 3). All of the PT 
compounds tested as well as the total PT fraction exhibited 
anti-inflammatory activity, but the extent of the effects were 
dependent on the specific compound and cytokine. IL-6 was 
not modulated by any of the PT treatments (data not shown). 
Interestingly, the total PT fraction exhibited the most potent 
modulatory effect, and its inhibitory power was comparable to 
that of dexamethasone (see the inhibition of IL-1E, IL-12p40, 
IL12p70 and TNF-D in Fig. 3). Among the isolated compounds, 
compound 3 was the strongest overall inhibitor of cytokine 
production (more than 50% inhibition for IL-1E, IL-12p40, 
IL-12p70 and TNF-D secretion, Fig. 3). Compound 2 was a 
strong inhibitor of IL-1E and TNF-D (more than 50% inhibition) 
but a weaker inhibitor of IL-12p40 and IL-12p70 (less than 50% 
inhibition). The novel compound 1 significantly inhibited 
IL-1E and TNF-D, but was weak at inhibiting IL-12p40 and 
IL-12p70. Finally, compounds 4 and 5 were the least active 
PT, as they significantly inhibited the production of only one 
of the tested cytokines (IL-12p40 and TNF-D, respectively) 
by DC (Fig. 3). Regarding NO production, an approximately 
similar profile of inhibition by PT was observed. Compound 
3 was the strongest inhibitor of the production of this 
mediator, followed by the total PT fraction. Compounds 1, 
2, 4 and 5 were essentially inactive at the concentration 
tested (Fig. 3).
Fig. 2 - SIM spectra in negative mode of different batches of the PT fraction.The retention time shows the mass spectrum 
of each major component: yarumic acid (1) m/z = 487; serjanic acid (2) m/z= 499; and spergulagenic acid A (3) m/z= 541. The 
retention times for compounds (4) and (5) are between (1) and (2) (data not shown).
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In summary, this investigation resulted in the discovery 
and identification of 1, a novel PT of the Oleanane family. 
Additionally, four known oleanane-type PT were also identified 
in the roots of C. telenitida (serjanic acid, spergulagenic acid A, 
goreishic acid I and 20-hydroxy-ursolic acid, with the first two 
being by far the most abundant in the total PT fraction). This 
is, to our knowledge, the first chemical characterisation of PT 
reported for this species. Our results are in agreement with 
previous reports of terpenoids as important active metabolites 
produced by the Cecropia genus (Costa et al., 2011; Schinella et 
al., 2008). Furthermore, our DC-based assay demonstrated that 
these PT are powerful inhibitors of proinflammatory cytokine 
production in this cell type, suggesting the potential of these 
compounds as immunoregulatory agents. We observed that 
the total PT fraction from C. telenitida exhibited a powerful 
inhibitory response in inflammatory DC, as assessed by the 
production of proinflammatory cytokines and NO. This effect 
was primarily reproduced by compounds 2 and 3, which 
were the two most abundant components in the PT fraction 
(representing the 95% of the total PT mass). The novel PT 1, 
which was less representative in the PT fraction (less than 
5% of the total PT mass) was also inhibitory, whereas the 
two minor compounds (5 and 4, representing less than 1% 
of the total PT fraction) exhibited the weakest of bioactivity 
(Fig. 3). These results suggest that 2 and 3 are responsible 
for the immunomodulatory activity of the PT fraction from 
C. telenitida in DC. In accordance to our results, a lupane-
type triterpenoid from natural origins also inhibited LPS-
Fig. 3 - Pentacyclic triterpenes from the roots of Cecropia telenitida are immunomodulatory in mouse DC. Cells were 
generated as described in the experimental section, pretreated with the indicated compound for 6 hours (10 μg/ml), 
followed by subsequent stimulation with LPS (0.1 μg/ml) for an additional 18 h. Cells treated only with LPS or with LPS plus 
dexamethasone were used as negative and positive controls, respectively. An additional control of cells treated with vehicle 
only (DMSO) was also included to confirm the responsiveness of DC to LPS. Supernatants were collected to evaluate cell 
viability, cytokine secretion and nitric oxide production. The results shown are the mean ± SEM of pooled data from two 
independent experiments (n = 2 each). Statistical significance of the results was determined by ANOVA using the Dunnett test 
for multiple comparisons to contrast the cytokine levels secreted by DC receiving multiple treatments to the amount secreted 
by DC treated with LPS only.ap < 0.05, bp < 0.01, cp < 0.001.
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c
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c
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stimulated cytokine production by mouse DC (Kim et al., 
2010). Interestingly, some reports have shown that other 
PT stimulate DC to mature and promote the activation of 
Th1 and Th2 cells in human (Jung et al., 2010) and mouse 
(Yu et al., 2009) models, respectively, suggesting structure- 
and/or species-dependent effects of PT on DC. Opposing 
effects on proinflammatory mediators (cytokines and NO), 
depending on the cellular status and environment, have also 
been reported with several prototypical PT in vitro (Choi et al., 
2001; Ikeda et al., 2007; Marquez-Martin et al., 2006; Suh et 
al., 1998; Yun et al., 2003). The in vivo implications of these 
apparently contradictory results remain unclear. Although 
PT have been shown to affect important signalling pathways 
involved in the inflammatory response, such as MAPK, 
NF-NB, Fas, PI3K/Akt and Wnt/E-catenin (Laszczyk, 2009; 
Poeckel and Werz, 2006; Saleem, 2009); future experiments are 
required to elucidate the molecular mechanisms mediating 
the modulatory effect reported here. However, because NF-NB 
is a major inflammatory signalling pathway triggered after 
TLR4-mediated activation by LPS in DC, we speculate that this 
could be a major mediator of PT action in our assays.
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